US emergency department visits for acute harms from over-the-counter cough and cold medications, 2017-2019
| Autor: | Maribeth C. Lovegrove, Rohan Mital, Nina J. Weidle, Jennifer N. Lind, Andrew I. Geller, Daniel S. Budnitz, Ruth N. Moro |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
education.field_of_study Drug-Related Side Effects and Adverse Reactions Epidemiology business.industry Cold medications Population Emergency department Injury surveillance United States Hospitalization Public health surveillance Cough Adverse drug event Emergency medicine medicine Adverse Drug Reaction Reporting Systems Humans Pharmacology (medical) Over-the-counter business Adverse effect education Child Emergency Service Hospital |
| Zdroj: | Pharmacoepidemiology and drug safetyREFERENCES. 31(2) |
| ISSN: | 1099-1557 |
| Popis: | BACKGROUND AND PURPOSE Characterization of emergency department (ED) visits for acute harms related to use of over-the-counter cough and cold medications (CCMs) by patient demographics, intent of CCM use, concurrent substance use, and clinical manifestations can help guide prevention of medication harms. METHODS Public health surveillance data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project were used to estimate numbers and population rates of ED visits from 2017 to 2019. RESULTS Based on 1396 surveillance cases, there were an estimated 26 735 (95% CI, 21 679-31 791) US ED visits for CCM-related harms annually, accounting for 1.3% (95% CI, 1.2-1.5%) of all ED visits for medication adverse events. Three fifths (61.4%, 95% CI, 55.6-67.2%) of these visits were attributed to non-therapeutic CCM use (nonmedical use, self-harm, unsupervised pediatric exposures). Most visits by children aged |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text